文献速递脑血管病外科神经重症

Barrow破裂动脉瘤试验(BRAT)中老年动脉瘤性蛛网膜下腔出血患者病例系列的结果

Outcomes in a Case Series of Elderly Patients with Aneurysmal Subarachnoid Hemorrhages in the Barrow Ruptured Aneurysm Trial (BRAT).
PubMed 文献 · World Neurosurg · 2020-04-15

该回顾性病例系列分析BRAT中动脉瘤性蛛网膜下腔出血老年患者,按年龄分为<60岁(n=268)、60-65岁(n=60)和≥65岁(n=77)三组。137例老年患者中121例有6年随访。≥65岁组功能预后不良比例高于60-65岁组(75% [52/69] vs 48% [25/52];OR 3.3;95%CI 1.5-7.1;P=0.002)。在Hunt-Hess评分≤3的患者中,≥65岁组6年随访功能预后不良比例亦高于60-65岁组(69% [35/51] vs 36% [14/39];OR 3.9;95%CI 1.6-9.4;P=0.003)。

要点

  • ≥65岁患者功能预后不良比例高于60-65岁患者(75% vs 48%;OR 3.3;95%CI 1.5-7.1;P=0.002)。
  • Hunt-Hess评分≤3时,≥65岁组6年功能预后不良比例高于60-65岁组(69% vs 36%;OR 3.9;95%CI 1.6-9.4;P=0.003)。
  • Hunt-Hess评分>3时,≥65岁组与60-65岁组功能预后无统计学显著差异。

核心结论

  • 老年动脉瘤性蛛网膜下腔出血患者功能预后不良风险高;Hunt-Hess评分良好者中60-65岁患者倾向优于≥65岁患者,而高级别患者无论年龄预后均差。

研究设计与样本

  • 回顾性分析Barrow破裂动脉瘤试验(BRAT)中因动脉瘤性蛛网膜下腔出血治疗的患者,按年龄分为<60岁(n=268)、60-65岁(n=60)和≥65岁(n=77)三组。
  • 老年队列按入院Hunt-Hess评分(>3 vs ≤3)及功能预后(改良Rankin量表评分>2)分析。

主要发现

  • 137例老年患者中121例完成6年随访。
  • ≥65岁组功能预后不良比例为75%(52/69),60-65岁组为48%(25/52)(OR 3.3;95%CI 1.5-7.1;P=0.002)。
  • Hunt-Hess评分≤3的患者(n=90)中,≥65岁组6年随访功能预后不良比例为69%(35/51),60-65岁组为36%(14/39)(OR 3.9;95%CI 1.6-9.4;P=0.003)。
  • Hunt-Hess评分>3的患者中,≥65岁组(n=18)与60-65岁组(n=13)功能预后无统计学显著差异。

临床怎么用

  • 作者认为,老年动脉瘤性蛛网膜下腔出血患者功能预后不良风险高,上述年龄分层结果可为临床决策和预后判断提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is debilitating in elderly patients, but literature regarding this population is scarce, and clinical decision-making remains debated. Outcomes of elderly patients with aSAH stratified by age and clinical presentation were analyzed. METHODS: Patients treated for aSAH were retrospectively analyzed. Patients were trichotomized into a young cohort (aged <60 years [n = 268]) and 2 elderly cohorts (aged 60-65 years [n = 60] and ≥65 years [n = 77]). The elderly cohorts were analyzed by poor or good scores at presentation (Hunt and Hess [HH] score >3 vs. ≤3, respectively) and poor functional outcome (modified Rankin Scale score >2). RESULTS: Of 137 elderly patients, 121 had a 6-year follow-up. The >65-year-olds (75% [52/69]) were more likely to have poor functional outcomes than the 60 to 65-year-olds (48% [25/52]) (odds ratio, 3.3; 95% confidence interval, 1.5-7.1; P = 0.002). Among those with an HH score ≤3 at presentation (n = 90), the >65-year-old cohort had poorer outcomes than the 60 to 65-year-old cohort at 6-year follow-up (69% [35/51] vs. 36% [14/39], respectively; odds ratio, 3.9; 95% confidence interval, 1.6-9.4; P = 0.003). Among patients with an HH score >3, no statistically significant differences in functional outcome were observed between the >65-year-old (n = 18) and 60 to 65-year-old (n = 13) cohorts. CONCLUSIONS: Elderly patients with aSAH are at high risk for poor functional outcomes. However, among those presenting with good HH scores, younger-elderly patients (aged 60-65 years) tend to fare better than older-elderly patients (aged >65 years). Elderly patients presenting with high-grade aSAH fare poorly regardless of age, which can inform clinical decision-making and prognostication.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Catapano JS, Louie CE, Lang MJ, et al. Outcomes in a Case Series of Elderly Patients with Aneurysmal Subarachnoid Hemorrhages in the Barrow Ruptured Aneurysm Trial (BRAT). World Neurosurg. 2020. PMID: 32304888. doi:10.1016/j.wneu.2020.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。